Cancer · 1993 · 53 citations · 16 references
MedicineOncologySurgeryChemotherapyPulmonologySurgical OncologyAntifungal TherapyLung Resection SurgeryPulmonary PathologyPulmonary ResectionRelapsed DiseaseThoracic SurgeryAspergillosis TherapyInvasive Aspergillosis ManagementInvasive Aspergillosis TreatmentInvasive Fungal Infection ManagementInvasive Pulmonary Fungal InfectionMedian AgePulmonary AspergillosisPulmonary Fungal Infections
BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality in patients with neutropenia. Two severe complications with poor outcome can be observed after apparently successful IPA medical treatment: severe hemoptysis and IPA relapse during subsequent cytotoxic treatments. Early surgical therapy has not been considered routinely in the management of localized IPA. METHODS: Six consecutive patients (four women, two men; median age, 52 years) with localized cavitating IPA diagnosed during chemotherapy-induced aplasia were treated with early surgical resection after hematologic recovery. RESULTS: All patients received a lobectomy. Surgery was uneventful. This procedures allows patients to proceed with further intensive chemotherapy and/or bone marrow transplantation without IPA reactivation. CONCLUSIONS: For selected patients, surgical resection of localized IPA with unique cavitating lesion, which prevents hemoptysis and IPA recurrence and allows for subsequent cytotoxic treatment, may be recommended.
16
Lyndsay Davies, G Quarrell · PubMed · 1985 · 407 citations
Treatment of invasive aspergillosis with itraconazole
David W. Denning, Richard Tucker, Linda Hansen et al. · The American Journal of Medicine · 1989 · 365 citations · Full text
Bruce D. Fisher, Donald Armstrong, B. Yu et al. · The American Journal of Medicine · 1981 · 291 citations